An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China

References

• Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, Shayo B, Giattas MR, Loharikar A, Lyimo D. National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation. Vaccine. 2022;40(Suppl 1):A2–9. doi:10.1016/j.vaccine.2021.04.025.
   PubMedGoogle Scholar
• Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17. doi:10.1128/CMR.16.1.1-17.2003.
   PubMed Web of Science ®Google Scholar
• Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131(9):1969–82. doi:10.1002/ijc.27650.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136(12):2752–60. doi:10.1002/ijc.29082.
   PubMed Web of Science ®Google Scholar
• Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, Brewer NT. Human papillomavirus vaccination and cervical cancer risk. BMJ. 2022;379:e070115. doi:10.1136/bmj-2022-070115.
   PubMedGoogle Scholar
• Zhang XX, Wang W, Song YF, Zhang ZN, Yu WZ. Expert recommendations on human papillomavirus vaccine immunization strategies in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56(9):1165–74. doi:10.3760/cma.j.cn112150-20220505-00443.
   PubMedGoogle Scholar
• Oliveira CR, Niccolai LM. Monitoring HPV vaccine impact on cervical disease: status and future directions for the era of cervical cancer elimination. Prev Med. 2021;144:106363. doi:10.1016/j.ypmed.2020.106363.
   PubMed Web of Science ®Google Scholar
• Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily M-C, Baldo V, Brassard P, Brotherton JML, Callander D, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. doi:10.1016/S0140-6736(19)30298-3.
   PubMed Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70. doi:10.1002/ijc.30716.
   PubMed Web of Science ®Google Scholar
• Steben M, Tan Thompson M, Rodier C, Mallette N, Racovitan V, DeAngelis F, Stutz M, Rampakakis E. A review of the impact and effectiveness of the quadrivalent human papillomavirus vaccine: 10 years of clinical experience in Canada. J Obstet Gynaecol Can. 2018;40(12):1635–45. doi:10.1016/j.jogc.2018.05.024.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–4.
   PubMed Web of Science ®Google Scholar
• Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94(6):2776–86. doi:10.1002/jmv.27478.
   PubMed Web of Science ®Google Scholar
• Hu YM, Guo M, Li C-G, Chu K, He W-G, Zhang J, Gu J-X, Li J, Zhao H, Wu X-H, et al. Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women. Sci China Life Sci. 2020;63(4):582–91. doi:10.1007/s11427-019-9547-7.
   PubMed Web of Science ®Google Scholar
• Abouelella DK, Canick JE, Barnes JM, Rohde RL, Watts TL, Adjei Boakye E, Osazuwa-Peters N. Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States. Hum Vaccin Immunother. 2022;18(7):2148825. doi:10.1080/21645515.2022.2148825.
   PubMedGoogle Scholar
• Purrinos-Hermida MJ, Santiago-Pérez MI, Treviño M, Dopazo R, Cañizares A, Bonacho I, Trigo M, Fernández ME, Cid A, Gómez D, et al. Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain. PLoS One. 2018;13(8):e0201653. doi:10.1371/journal.pone.0201653.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou J, Huang Q, Si M-Y, Su X-Y, Li J. Status of human papillomavirus vaccination and knowledge, attitudes, and influencing factors towards human papillomavirus and its vaccines among university students in Western China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43(4):545–50. doi:10.3881/j.issn.1000-503X.13153.
   PubMedGoogle Scholar
• Xue L, Hu W, Zhang H, Xie Z, Zhang X, Zhao F, Qiao Y, Gao L, Ma W. Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China. Hum Vaccin Immunother. 2018;14(2):404–11. doi:10.1080/21645515.2017.1393132.
   PubMed Web of Science ®Google Scholar
• Deng C, Chen X, Liu Y. Human papillomavirus vaccination: coverage rate, knowledge, acceptance, and associated factors in college students in mainland China. Hum Vaccin Immunother. 2021;17(3):828–35. doi:10.1080/21645515.2020.1797368.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li M, Li X, Bai H, Gao J, Liu H. Knowledge of cervical cancer prevention and treatment, and willingness to receive HPV vaccination among college students in China. BMC Public Health. 2022;22(1):2269. doi:10.1186/s12889-022-14718-0.
   PubMed Web of Science ®Google Scholar
• Khan TM, Buksh MA, Rehman IU, Saleem A. Knowledge, attitudes, and perception towards human papillomavirus among university students in Pakistan. Papillomavirus Res. 2016;2:122–7. doi:10.1016/j.pvr.2016.06.001.
   PubMed Web of Science ®Google Scholar
• Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015;33(8):1001–7. doi:10.1016/j.vaccine.2015.01.009.
   PubMed Web of Science ®Google Scholar
• Winarto H, Habiburrahman M, Dorothea M, Wijaya A, Nuryanto KH, Kusuma F, Utami TW, Anggraeni TD. Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination. PLoS One. 2022;17(5):e0266139. doi:10.1371/journal.pone.0266139.
   PubMed Web of Science ®Google Scholar
• Levine GN, D’Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin. 2010;60(3):194–201. doi:10.3322/caac.20061.
   PubMed Web of Science ®Google Scholar
• Esagoff A, Cohen SA, Chang G, Equils O, Van Orman S. Human papillomavirus and Chinese international students in the United States: attitudes, knowledge, vaccination trends, healthcare behaviors, and sexual activity. Hum Vaccin Immunother. 2022;18(1):1882283. doi:10.1080/21645515.2021.1882283.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Xu L, Simoens C, Martin‐Hirsch, PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2011;2011(4).
   PubMedGoogle Scholar
• Qiao YL, Wu T, Li R-C, Hu Y-M, Wei L-H, Li C-G, Chen W, Huang S-J, Zhao F-H, Li M-Q, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J Natl Cancer Inst. 2020;112(2):145–53. doi:10.1093/jnci/djz074.
   PubMedGoogle Scholar
• Zhou L, Gu B, Xu X, Li Y, Cheng P, Huo Y, Liu G, Zhang X. On imported and domestic human papillomavirus vaccines: cognition, attitude, and willingness to pay in Chinese medical students. Front Public Health. 2022;10:863748. doi:10.3389/fpubh.2022.863748.
   PubMed Web of Science ®Google Scholar
• Lopez N, Salamanca de la Cueva I, Vergés E, Suárez Vicent E, Sánchez A, López AB, Panizo-Santos MB, Garcés-Sánchez M, Montesdeoca A, Rivera AJ, et al. Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study). Hum Vaccin Immunother. 2022;18(1):2024065. doi:10.1080/21645515.2021.2024065.
   PubMed Web of Science ®Google Scholar